immunology applications final review

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/26

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

27 Terms

1
New cards

Why are vaccines important?

Vaccines are our main defense against viral pathogens and have drastically reduced disease-related mortality alongside sanitation.

2
New cards

What diseases currently lack effective vaccines?

HIV and Plasmodium spp. (malaria).

3
New cards

What is the historical origin of vaccination?

12th century China used variolation; Edward Jenner developed modern vaccination.

4
New cards

What challenges are associated with vaccines?

Storage issues, vaccine-associated risks, high development cost, low profit, and delivery limitations.

5
New cards

What are features of an ideal vaccine?

100% effective and safe, single dose, no transmission, long shelf life, room temperature stable, cheap, and induces herd immunity.

6
New cards

What is active immunization?

Stimulation of humoral and cell-mediated immune responses using antigenic material to induce memory.

7
New cards

How do vaccines mimic infection?

They trigger a primary immune response so that future exposures cause a faster, stronger secondary response.

8
New cards

What is a prophylactic vaccine?

A vaccine administered before exposure to prevent disease (e.g., polio vaccine).

9
New cards

What is a palliative vaccine?

A vaccine used to stimulate the immune system after infection (e.g., cancer or HIV vaccines).

10
New cards

What is an attenuated vaccine?

A live but weakened pathogen that triggers strong CMI and humoral immunity.

11
New cards

What are risks of attenuated vaccines?

Reversion to virulence, risk to immunocompromised and pregnant individuals.

12
New cards

What is an inactivated (killed) vaccine?

A vaccine made from whole microbes killed by chemicals or heat; safer but may require boosters.

13
New cards

What is a whole-agent vaccine?

An inactivated vaccine using the entire deactivated microbe.

14
New cards

What is an adjuvant?

A substance added to vaccines to increase antigenicity and enhance immune response.

15
New cards

What is a toxoid vaccine?

Chemically or thermally modified toxins used to induce immunity (e.g., tetanus, diphtheria).

16
New cards

What is a subunit vaccine?

A vaccine using recombinant DNA to produce pure antigen (e.g., Hepatitis B vaccine).

17
New cards

What is a DNA or mRNA vaccine?

A vaccine using genetic material (e.g., coronavirus mRNA in lipid envelopes).

18
New cards

What are some safety concerns with vaccines?

Mild toxicity (fever, soreness), risk of disease in immunocompromised from live vaccines.

19
New cards

What limits vaccine effectiveness?

Limited strain coverage, non-immunizing diseases, and rapid mutation (e.g., flu virus).

20
New cards

What is passive immunization?

Injection of preformed antibodies to provide temporary protection.

21
New cards

What are problems with passive immunization?

Short-lived immunity, risk of serum sickness, contamination, and unwanted antibody responses.

22
New cards

What is a hybridoma?

A fused plasma cell and myeloma cell that produces monoclonal antibodies.

23
New cards

What are monoclonal antibodies?

Identical, pure antibodies made by hybridomas; used therapeutically (e.g., for COVID-19).

24
New cards

What types of immunity exist?

Natural active (infection), artificial active (vaccination), natural passive (maternal antibodies), artificial passive (injected antibodies).

25
New cards

How is molecular biology used in vaccine development?

Recombinant DNA and genetic engineering allow production of specific, pure antigens and RNA-based vaccines.

26
New cards

What are vaccine antigens?

Microbes, microbial parts, proteins, polysaccharides, or toxins used to elicit an immune response.

27
New cards

What are current difficulties in vaccine development?

Rapid mutation, disease not being immunizing, limited strain coverage, cost, and public health issues.